Medical Health Cluster

SARS-CoV-2

SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus

SARS-CoV-2, or at least pieces of it, sticks around longer in some infected individuals than respiratory sample testing would suggest, a recent study found. After respiratory samples tested negative, a small proportion of the 113 study participants continued to shed SARS-CoV-2 RNA in their feces—about 4% of them for at least […]

Read More

FDA Authorizes Pfizer’s COVID-19 Booster for Children Ages 5 to 11

The FDA expanded an emergency use authorization (EUA) today allowing the Pfizer-BioNTech COVID-19 booster shot for children between the ages of 5 to 11 who are at least 5 months out from their first vaccine series. According to the most recent data from the Centers for Disease Control and Prevention, […]

Read More

Mayo Clinic Q&A podcast: COVID-19 update

The widespread availability of at-home COVID-19 tests have made it easier for people to know if they have the virus, and to take measures to protect themselves and others. But there is a downside. Because the majority of tests are now done at home and often not reported, the official counts on […]

Read More

La calculadora de riesgo quirúrgico del American College of Surgeons es eficaz para pacientes mexicanos en el contexto de urgencias

Un equipo de médicos encontró que la calculadora de riesgo quirúrgico ACS NSQIP, del American College of Surgeons (ACS), predice la mayoría de complicaciones posoperatorias y estima los días de estancia hospitalaria de pacientes mexicanos operados en un escenario de urgencias.[1] Y aunque no fue eficaz para predecir neumonía, infección de vías urinarias o readmisión hospitalaria, […]

Read More

Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3

Older patients in Israel who received a fourth dose of the BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine were more than 3 times less likely to develop severe COVID-19 than those who received only 3 doses. But while protection against severe disease did not wane during the testing period, protection against confirmed infection […]

Read More

SARS-CoV-2 Stays in GI Tract Long After It Clears the Lungs

New data present further evidence that SARS-CoV-2 infection can settle in the gastrointestinal (GI) tract and that it can persist long after the infection has cleared the lungs. Infection of the GI tract may figure prominently in long COVID, the study authors suggest. Led by Aravind Natarajan, PhD, with the […]

Read More

CDC Predicts a Rise in COVID Hospitalizations and Deaths in Coming Weeks

Coronavirus-related hospital admissions and deaths in the U.S. are projected to increase over the next four weeks, according to a national forecast used by the CDC. The national model also predicts that about 5,000 deaths will occur over the next two weeks, with Ohio, New Jersey, and New York projected to see the largest […]

Read More

Long COVID ‘Brain Fog’ Shares Features With ‘Chemo Brain’

The “brain fog” reported by some people after COVID-19 shows striking similarities to the condition known as “chemo brain” – the mental cloudiness some people experience during and after cancer treatment, according to new research. People who had COVID-19 “frequently experience lingering neurological symptoms, including impairment in attention, concentration, speed […]

Read More

COVID-19 Infection Has More Than 50
Long-Term Effects

MADRID, Spain — Clinical experiences in approaching COVID-19 from different perspectives, results obtained by various therapeutic options and, above all, the challenges posed by a new healthcare reality — long COVID — were all the focus of a recent discussion at the 7th International Congress of the Spanish Society of Precision […]

Read More